Thus, the present work identifies the novel axis “hypoxia-ATP6V1A-metabolic reprogramming-anti-aging” and offers further mechanistic insights into bone aging and additional potential intervention targets for metabolic and oxidative stress-related degenerative diseases. The gene discussed is ATP6V1A; the disease is neurodegenerative disease.